Psychedelics are being used globally in a variety of contexts, from recreational use to controlled clinical trials of therapeutic applications. Much of what is known about psychedelic user experiences comes from quantitative studies, while qualitative research is limited and has received comparatively less attention. Qualitative research, particularly personal narratives, can highlight the nuanced impact users have experienced, which quantitative research may be unable to capture. The present study is an exploratory analysis of qualitative responses from the Global Psychedelic Survey 2023, aimed at addressing the gap between quantitative and qualitative literature in naturalistic psychedelic use. Using inductive thematic analysis, three common themes in participants’ accounts of their psychedelic experiences were identified: perceived therapeutic outcomes, enhanced psychological wellbeing and personal development, and profound shifts in life perspective and meaning. Such narratives bring forth detailed accounts of the impact psychedelic users have experienced, as well as potential risks associated with and experienced by participants. Findings are discussed in the context of harm reduction, public policy, and future inquiry into psychedelic substances for health applications.
Robinson et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: